In CRC, CHD7 was amplified in 331 cases (53.7%) (Figure S3), mutated with a frequency of 8%, identified with four gene fusion events, and more overexpressed in tumour tissues than in the adjacent normal tissues. Here, CHD7 is linked to colorectal carcinoma.